Valuation: Divi's Laboratories Limited

Market Cap 2,489B 25.94B 22.62B 21.36B 19.39B 36.33B 36.49B 256B 98.72B 1,265B 97.43B 95.27B 4,071B P/E 2027 *
76.3x
P/E 2028 * 63.3x
Enterprise Value 2,454B 25.57B 22.3B 21.06B 19.12B 35.82B 35.97B 252B 97.33B 1,248B 96.06B 93.93B 4,014B EV / Sales 2027 *
19.5x
EV / Sales 2028 * 16.3x
Free-Float
47.99%
Yield 2027 *
0.38%
Yield 2028 * 0.41%
1 day+0.56%
1 week-0.67%
Current month-0.97%
1 month+10.53%
3 months+40.69%
6 months+54.03%
Current year+46.66%
1 week 8,923
Extreme 8923
9,445
1 month 8,457.5
Extreme 8457.5
9,615
Current year 5,647.5
Extreme 5647.5
9,615
1 year 5,636.5
Extreme 5636.5
9,615
3 years 3,295.3
Extreme 3295.3
9,615
5 years 2,730
Extreme 2730
9,615
10 years 532.65
Extreme 532.65
9,615
Manager TitleAgeSince
Chief Executive Officer 75 26/11/2009
Chief Executive Officer 48 04/01/2020
Director of Finance/CFO 65 01/08/2025
Director TitleAgeSince
Director/Board Member 48 26/11/2009
Chairman 75 26/11/2009
Director/Board Member 68 01/10/1994
Date Insider Type Main position Quantity % Market Cap. Importance
26/3/25 Sell

Executive/Senior Manager

25,000 0.0094%
15/3/25 Sell 300 0.0001%
17/2/25 Sell 500 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
+0.56%-0.67%+54.92%+145.71% 25.84B
-0.48%+2.60%+50.04%+100.38% 1,027B
+0.29%+1.94%+55.44%+66.63% 651B
+0.27%+2.77%+19.03%+71.64% 467B
-1.22%+3.66%+36.44%+38.32% 350B
-0.79%+2.73%+19.03%+25.08% 268B
+0.58%+6.76%+11.13%+16.52% 257B
+1.01%+1.50%+38.85%+45.54% 205B
+0.79%+1.84%-28.27%-56.71% 190B
+0.12%+5.06%+32.89%+99.68% 187B
Average +0.08%+2.12%+28.95%+55.28% 362.8B
Weighted average by Cap. -0.09%+2.60%+35.09%+62.10%

Financials

2027 *2028 *
Net sales 126B 1.31B 1.14B 1.08B 980M 1.84B 1.84B 12.93B 4.99B 63.93B 4.92B 4.81B 206B 150B 1.56B 1.36B 1.29B 1.17B 2.19B 2.2B 15.41B 5.95B 76.21B 5.87B 5.74B 245B
Net income 32.65B 340M 297M 280M 254M 477M 479M 3.36B 1.29B 16.6B 1.28B 1.25B 53.41B 39.42B 411M 358M 338M 307M 575M 578M 4.05B 1.56B 20.04B 1.54B 1.51B 64.48B
Net Debt -35B -365M -318M -300M -273M -511M -513M -3.6B -1.39B -17.79B -1.37B -1.34B -57.25B -44.85B -467M -408M -385M -349M -655M -658M -4.61B -1.78B -22.8B -1.76B -1.72B -73.38B
Logo Divi's Laboratories Limited
Divi's Laboratories Limited is specialized in the development and manufacture of active pharmaceutical ingredients, intermediates and nutraceutical ingredients. Net sales by source of revenue break down into product sales (97.9%) and service sales (2.1%). At the end of March 2020, the group has 2 production sites located in India.
Employees
11,565
Date Price Change Volume
18/09/26 INR 9,375.00 +0.56% 691,534
17/09/26 INR 9,323.00 +1.80% 494,167
16/09/26 INR 9,158.00 -0.43% 878,300
15/09/26 INR 9,198.00 -1.33% 380,826
11/09/26 INR 9,322.00 -1.23% 516,756
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
9,375.00INR
Average target price
8,447.00INR
Spread / Average Target
-9.90%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DIVISLAB Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!